CONTENTS:
- First do no harm: developing interventions that combat addiction without increasing inequalities [Editorial]. Bambra C., p. 787-788.
- Will growth in cryptomarket drug buying increase the harms of illicit drugs? [Addiction debate]. Aldridge J., Stevens A., Barratt M.J., p. 789-796.
- Cryptomarkets, systemic violence and the 'gentrification hypothesis'. Martin J., p. 797-798.
- Focus on cryptomarkets and online reviews too narrow to debate harms of drugs bought online. van der Gouwe D., Rigter S., Brunt T.M., p. 798-799.
- Looking to the future - more concern than optimism that cryptomarkets will reduce drug-related harms. Mounteney J., Cunningham A., Groshkova T., Sedefov R., Griffiths P., p. 799-800.
- The harm reduction impact of cryptomarkets: inequality and opportunity. Sumnall H.R., p. 801-802.
- Harms, benefits and the policing of cryptomarkets: a response to commentaries. Aldridge J., Stevens A., Barratt M.J., p. 802-804.
- Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Rosen L.J., Galili T., Kott J., Goodman M., Freedman L.S., p. 805-816.
- Motivation to reduce alcohol consumption and subsequent attempts at reduction and changes in consumption in increasing and higher-risk drinkers in England: a prospective population survey. de Vocht F., Brown J., Beard E., West R., Michie S., Campbell R., et al., p. 817-827.
- Estimating the drink driving attributable fraction of road traffic deaths in Mexico. Santoyo-Castillo D., Perez-Nunez R., Borges G., Hijar M., p. 828-835.
- Trends in alcohol-related mortality in East and West Germany, 1980-2014: age, period and cohort variations. Piontek D., Kraus L., p. 836-844.
- Lifetime marijuana use and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Auer R., Sidney S., Goff D., Vittinghoff E., Pletcher M.J., Allen N.B., et al., p. 845-856.
- Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration. Westover A.N., Nakonezny P.A., Halm E.A., Adinoff B., p. 857-867.
- Direct-acting antiviral treatment of chronic HCV-infected patients on opioid substitution therapy: Still a concern in clinical practice? Christensen S., Buggisch P., Mauss S., Boker K.H.W., Schott E., Klinker H., et al., p. 868-882.
- Brief telephone interventions for problem gambling: a randomized controlled trial. Abbott M., Hodgins D.C., Bellringer M., Vandal A.C., Palmer Du Preez K., Landon J., et al., p. 883-895.
- E-cigarette price sensitivity among middle- and high-school students: evidence from monitoring the future. Pesko M.F., Huang J., Johnston L.D., Chaloupka F.J., p. 896-906.
- Validation of a contextualized assessment of smoking behaviour in students. Larsen H., Salemink E., Grond I., Wiers R.W., Anderson K.G., p. 907-913.
- Improving quit rates of web-delivered interventions for smoking cessation: full-scale randomized trial of WebQuit.org versus Smokefree.gov. Bricker J.B., Mull K.E., McClure J.B., Watson N.L., Heffner J.L., p. 914-923.
- The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys. Degenhardt L., Saha S., Lim C.C.W., Aguilar-Gaxiola S., Al-Hamzawi A., Alonso J., et al., p. 924-934.
- Commentary on Degenhardt et al. (2018): Cause or consequence? Disentangling the relationship between psychosis and substance use. DeVylder J.E., Oh H.Y., Kelleher I., p. 935-936.
- Incidence and risk factors for mortality after release from prison in Australia: a prospective cohort study. Forsyth S.J., Carroll M., Lennox N., Kinner S.A., p. 937-945.
- Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy. Bogdanowicz K.M., Stewart R., Chang C.K., Shetty H., Khondoker M., Day E., et al., p. 946-951.
- Opioid dependence and pregnancy in early twentieth-century America. Tauger N., p. 952-957.
- Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids. Cousijn J., Nunez A.E., Filbey F.M., p. 958-966.